Quanterix (QTRX) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)
Powered by 
Analysis
Quanterix (QTRX) Net Income towards Common Stockholders Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.43 Bn | 221.37 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 144.26 Bn | 139.91 Bn | 3.61 Bn | 56.76% |
| 3 | Agilent Technologies | 40.88 Bn | 39.12 Bn | 1.04 Bn | 7.74% |
| 4 | Illumina | 30.92 Bn | 29.75 Bn | 770.00 Mn | -11.91% |
| 5 | Revvity | 13.86 Bn | 12.84 Bn | 416.87 Mn | -3.94% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 179.36% |
| 7 | Bio-Rad Laboratories | 10.10 Bn | 8.48 Bn | 345.80 Mn | 16.87% |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | -66.31% |
| 9 | 10x Genomics | 8.74 Bn | 8.18 Bn | 112.50 Mn | -151.92% |
| 10 | Quanterix | 125.23 Mn | 31.70 Mn | 12.67 Mn | -63.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.04% |
| Mar 31, 2026 | 14.45% |
| Dec 31, 2025 | -98.80% |
| Sep 30, 2025 | -301.26% |
| Jun 30, 2025 | -306.29% |
| Mar 31, 2025 | -83.68% |
| Dec 31, 2024 | -31.94% |
| Sep 30, 2024 | -24.37% |
| Jun 30, 2024 | -33.08% |
| Mar 31, 2024 | -53.46% |
| Dec 31, 2023 | 51.57% |
| Sep 30, 2023 | 81.63% |
| Jun 30, 2023 | 79.37% |
| Mar 31, 2023 | 59.41% |
| Dec 31, 2022 | -1.74% |
| Sep 30, 2022 | -133.38% |
| Jun 30, 2022 | -126.16% |
| Mar 31, 2022 | -77.36% |
| Dec 31, 2021 | -82.12% |
| Sep 30, 2021 | -810.89% |